Position
President
Company
Vergent Bioscience
MinneapolisBiotechnologyHealth CareTherapeuticsDescription
Vergent Bioscience has announced the appointment of Adam Gridley as its President and Chief Executive Officer, succeeding John Santini, who transitions to Chief Technology Officer. This leadership change positions Vergent for its next growth phase toward commercialization and pipeline development.
Quick answer
Vergent Bioscience Appoints Adam Gridley as Chief Executive Officer (June 9, 2026). Vergent Bioscience is based in Minneapolis, Minnesota, United States.
- Who is the new President at Vergent Bioscience?
- Vergent Bioscience named Adam Gridley President, announced June 9, 2026.
- What did Vergent Bioscience announce on June 9, 2026?
- Vergent Bioscience has announced the appointment of Adam Gridley as its President and Chief Executive Officer, succeeding John Santini, who transitions to Chief Technology Officer. This leadership change positions Vergent for its next growth phase toward commercialization and pipeline development.
- What does Vergent Bioscience do?
- Vergent Bioscience is a clinical-stage biotechnology company that is helping surgeons realize the full potential of minimally invasive and robotic-assisted surgery by significantly improving the visibility of tumors.
- Where is Vergent Bioscience based?
- Vergent Bioscience is based in Minneapolis, Minnesota, United States.
- Which similar companies made leadership changes around the same time?
- MitoRx Therapeutics (June 9, 2026), Lakefront Biotherapeutics NV (June 8, 2026), AdvanCell (June 8, 2026) and Poxel (June 10, 2026) also announced leadership changes within 45 days of Vergent Bioscience.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- MitoRx Appoints Alison Strutt as Chief Financial Officer and László Tankó as Chief Marketing Officer (June 9, 2026)
- Lakefront Biotherapeutics Appoints Eric Hedrick as Chief Medical Officer (June 8, 2026)
- AdvanCell Appoints Justyna Kelly as Chief Technology Officer and François Gaudet as Chief Scientific Officer (June 8, 2026)
- Poxel Appoints Yves Decadt as Chief Executive Officer (June 10, 2026)
- Bicara Therapeutics Appoints New Class II Directors (June 10, 2026)
- Oriva Therapeutics Appoints Dr Agnès Arbat as Chief Executive Officer and Chief Medical Officer (June 11, 2026)
Who to call at Vergent Bioscience, and when
A new leader at Vergent Bioscience brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Vergent Bioscience raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Vergent Bioscience, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Vergent Bioscience. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Vergent Bioscience changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Vergent Bioscience changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.